139 related articles for article (PubMed ID: 37442520)
21. A c-Fos activation map in nitroglycerin/levcromakalim-induced models of migraine.
Wu S; Ren X; Zhu C; Wang W; Zhang K; Li Z; Liu X; Wang Y
J Headache Pain; 2022 Sep; 23(1):128. PubMed ID: 36180824
[TBL] [Abstract][Full Text] [Related]
22. Aryl hydrocarbon receptors improve migraine-like pain behaviors in rats through the regulation of regulatory T cell/T-helper 17 cell-related homeostasis.
Yang L; Zhou Y; Zhang L; Wang Y; Zhang Y; Xiao Z
Headache; 2023 Sep; 63(8):1045-1060. PubMed ID: 37539825
[TBL] [Abstract][Full Text] [Related]
23. Glucagon-like Peptide-1 receptor Tie2+ cells are essential for the cardioprotective actions of liraglutide in mice with experimental myocardial infarction.
McLean BA; Wong CK; Kabir MG; Drucker DJ
Mol Metab; 2022 Dec; 66():101641. PubMed ID: 36396031
[TBL] [Abstract][Full Text] [Related]
24. Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension.
Helmstädter J; Frenis K; Filippou K; Grill A; Dib M; Kalinovic S; Pawelke F; Kus K; Kröller-Schön S; Oelze M; Chlopicki S; Schuppan D; Wenzel P; Ruf W; Drucker DJ; Münzel T; Daiber A; Steven S
Arterioscler Thromb Vasc Biol; 2020 Jan; 40(1):145-158. PubMed ID: 31747801
[TBL] [Abstract][Full Text] [Related]
25. Activation of the nuclear factor E2-related factor 2/anitioxidant response element alleviates the nitroglycerin-induced hyperalgesia in rats.
Di W; Shi X; Lv H; Liu J; Zhang H; Li Z; Fang Y
J Headache Pain; 2016 Dec; 17(1):99. PubMed ID: 27778243
[TBL] [Abstract][Full Text] [Related]
26. Analgesia effect of baicalein against NTG-induced migraine in rats.
Zhang XF; Zhang WJ; Dong CL; Hu WL; Sun YY; Bao Y; Zhang CF; Guo CR; Wang CZ; Yuan CS
Biomed Pharmacother; 2017 Jun; 90():116-121. PubMed ID: 28343071
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of Nerve Growth Factor Signaling Alleviates Repeated Dural Stimulation-induced Hyperalgesia in Rats.
Zhou H; Wang X; Wang S; Liu C; Fu Q; Qin G; Zhou J; Chen L
Neuroscience; 2019 Feb; 398():252-262. PubMed ID: 30553789
[TBL] [Abstract][Full Text] [Related]
28. PD-L1 and PD-1 expressed in trigeminal ganglia may inhibit pain in an acute migraine model.
Shi S; Han Y; Wang D; Guo P; Wang J; Ren T; Wang W
Cephalalgia; 2020 Mar; 40(3):288-298. PubMed ID: 31640402
[TBL] [Abstract][Full Text] [Related]
29. The role of the transient receptor potential ankyrin type-1 (TRPA1) channel in migraine pain: evaluation in an animal model.
Demartini C; Tassorelli C; Zanaboni AM; Tonsi G; Francesconi O; Nativi C; Greco R
J Headache Pain; 2017 Sep; 18(1):94. PubMed ID: 28884307
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine.
Greco R; Francavilla M; Demartini C; Zanaboni AM; Sodergren MH; Facchetti S; Pacchetti B; Palmisani M; Franco V; Tassorelli C
J Headache Pain; 2023 May; 24(1):48. PubMed ID: 37138206
[TBL] [Abstract][Full Text] [Related]
31. Temporal characteristics of astrocytic activation in the TNC in a mice model of pain induced by recurrent dural infusion of inflammatory soup.
Zhang L; Lu C; Kang L; Li Y; Tang W; Zhao D; Yu S; Liu R
J Headache Pain; 2022 Jan; 23(1):8. PubMed ID: 35033010
[TBL] [Abstract][Full Text] [Related]
32. Glucagon-like peptide-1 receptor mediates the beneficial effect of liraglutide in an acute lung injury mouse model involving the thioredoxin-interacting protein.
Zhou W; Shao W; Zhang Y; Liu D; Liu M; Jin T
Am J Physiol Endocrinol Metab; 2020 Sep; 319(3):E568-E578. PubMed ID: 32723174
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of metabotropic glutamate receptor 5 alleviates central sensitization by activating autophagy via inhibiting mTOR pathway in a rat model of chronic migraine.
Niu Y; Zeng X; Qin G; Zhang D; Zhou J; Chen L
Neurosci Lett; 2021 Jan; 743():135552. PubMed ID: 33352285
[TBL] [Abstract][Full Text] [Related]
34. Liraglutide, a glucagon-like peptide-1 receptor agonist, suppresses osteoclastogenesis through the inhibition of NF-κB and MAPK pathways via GLP-1R.
Li Z; Li S; Wang N; Xue P; Li Y
Biomed Pharmacother; 2020 Oct; 130():110523. PubMed ID: 32702632
[TBL] [Abstract][Full Text] [Related]
35. Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT), extracellular signal-related kinase (ERK)1/2, and cAMP/protein kinase A (PKA) signaling pathways involving β-catenin.
Wu X; Li S; Xue P; Li Y
Exp Cell Res; 2017 Nov; 360(2):281-291. PubMed ID: 28919123
[TBL] [Abstract][Full Text] [Related]
36. NR2B-Tyr phosphorylation regulates synaptic plasticity in central sensitization in a chronic migraine rat model.
Wang XY; Zhou HR; Wang S; Liu CY; Qin GC; Fu QQ; Zhou JY; Chen LX
J Headache Pain; 2018 Nov; 19(1):102. PubMed ID: 30400767
[TBL] [Abstract][Full Text] [Related]
37. Liraglutide, a Glucagon-like Peptide-1 Receptor Agonist, Attenuates Development of Cardiac Allograft Vasculopathy in a Murine Heart Transplant Model.
Wang Z; Wang M; Hu X; Li Y; Ma D; Li S; Zhao G; Xie Y; Shu Y; Yang J
Transplantation; 2019 Mar; 103(3):502-511. PubMed ID: 30211824
[TBL] [Abstract][Full Text] [Related]
38. D2 dopamine receptor-mediated mechanisms of dopaminergic system modulation in in vivo and in vitro experimental models of migraine.
Baranoglu Kilinc Y; Torun IE; Kilinc E
Eur J Neurosci; 2024 Mar; 59(6):1177-1193. PubMed ID: 37539658
[TBL] [Abstract][Full Text] [Related]
39. Expression of the glucagon-like peptide-1 receptor and its role in regulating autophagy in endometrial cancer.
Kanda R; Hiraike H; Wada-Hiraike O; Ichinose T; Nagasaka K; Sasajima Y; Ryo E; Fujii T; Osuga Y; Ayabe T
BMC Cancer; 2018 Jun; 18(1):657. PubMed ID: 29907137
[TBL] [Abstract][Full Text] [Related]
40. Soluble guanylyl cyclase is a critical regulator of migraine-associated pain.
Ben Aissa M; Tipton AF; Bertels Z; Gandhi R; Moye LS; Novack M; Bennett BM; Wang Y; Litosh V; Lee SH; Gaisina IN; Thatcher GR; Pradhan AA
Cephalalgia; 2018 Jul; 38(8):1471-1484. PubMed ID: 29022756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
